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THE SAFETY AND EFFICACY OF DRUG ELUTING STENTS IN
POST-HEART ATTACK RECOVERY

Alex Hahn. and Dr. Nicolas Sharnmas*
Biology Department, Illinois Wesleyan University
Midwest Cardiovascular Research Foundation

Recent concerns regarding the safety and efficacy of drug-eluting stents has led to further studies
in post-heart attack recovery. Some researchers report an increased incidence of acute stent
thrombosis (AST) leading to subsequent myocardial infarctions within the stented regions of the
heart after anti-platelet drugs have been discontinued. The purpose of this study was to
determine the safety and efficacy of Taxus® drug eluting stent and the correlation between the
length of anti-platelet administration and further problems. The study population included
patients who had an ST-elevated myocardial infarction within the past three years and were
given drug eluting stents. Excluded patients included those who had bare metal stents, those
who could not tolerate anti-platelet therapy, and those patients who had stents implanted prior to
the study's beginning. Patients were interviewed and records were obtained from consenting
individuals. Endpoints of death, incidence of acute stent thrombosis, and of recurrent myocardial
infarction due to either target lesion revascularization or target vessel revascularization were
determined. The results of this study will be used to evaluate any relationship recurrent heart
attack, acute stent thrombosis and length of anti-platelet therapy.

